Total Payments
$28,865
2024 Payments
$748.06
Companies
29
Transactions
220
Medicare Patients
5,508
Medicare Billing
$346,110
Payment Breakdown by Category
Other$22,100 (76.6%)
Food & Beverage$5,628 (19.5%)
Travel$1,110 (3.8%)
Education$26.52 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,100 | 13 | 76.6% |
| Food and Beverage | $5,628 | 195 | 19.5% |
| Travel and Lodging | $1,110 | 10 | 3.8% |
| Education | $26.52 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $24,235 | 59 | $0 (2023) |
| Boston Scientific Corporation | $1,171 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $712.11 | 41 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $494.50 | 21 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $368.76 | 8 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $322.73 | 7 | $0 (2024) |
| Siemens Medical Solutions USA, Inc. | $227.70 | 2 | $0 (2024) |
| Amgen Inc. | $204.56 | 13 | $0 (2024) |
| HeartFlow, Inc. | $190.72 | 4 | $0 (2022) |
| PFIZER INC. | $174.73 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $748.06 | 30 | Siemens Medical Solutions USA, Inc. ($227.70) |
| 2023 | $652.60 | 24 | E.R. Squibb & Sons, L.L.C. ($216.45) |
| 2022 | $467.43 | 15 | AstraZeneca Pharmaceuticals LP ($164.61) |
| 2021 | $4,282 | 22 | AstraZeneca Pharmaceuticals LP ($4,085) |
| 2020 | $5,306 | 31 | AstraZeneca Pharmaceuticals LP ($4,876) |
| 2019 | $6,484 | 36 | AstraZeneca Pharmaceuticals LP ($5,863) |
| 2018 | $10,621 | 44 | AstraZeneca Pharmaceuticals LP ($9,107) |
| 2017 | $303.34 | 18 | Novartis Pharmaceuticals Corporation ($156.48) |
All Payment Transactions
220 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/05/2024 | Siemens Medical Solutions USA, Inc. | NAEOTOM Alpha (Device) | Food and Beverage | In-kind items and services | $191.30 | General |
| Category: CT and RO incl. Computed Tomography and Radiation Oncology | ||||||
| 11/04/2024 | Siemens Medical Solutions USA, Inc. | NAEOTOM Alpha (Device) | Travel and Lodging | In-kind items and services | $36.40 | General |
| Category: CT and RO incl. Computed Tomography and Radiation Oncology | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.85 | General |
| Category: Cardiovascular | ||||||
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: DIABETES | ||||||
| 09/14/2024 | Terumo Medical Corporation | — | Food and Beverage | In-kind items and services | $26.41 | General |
| 09/09/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/30/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $22.52 | General |
| Category: Cardiology | ||||||
| 08/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Obesity | ||||||
| 08/19/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/16/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Not Applicable | ||||||
| 07/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Cardiology | ||||||
| 06/24/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 06/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/18/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/17/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Vascular | ||||||
| 06/04/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/31/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.89 | General |
| Category: Cardiovascular | ||||||
| 05/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: DIABETES | ||||||
| 05/09/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.92 | General |
| 04/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Cardiology | ||||||
| 04/16/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,376 | 1,562 | $261,137 | $81,169 |
| 2022 | 22 | 1,286 | 1,488 | $245,302 | $80,016 |
| 2021 | 22 | 1,442 | 1,717 | $257,023 | $96,881 |
| 2020 | 24 | 1,404 | 1,610 | $241,686 | $88,044 |
Total Patients
5,508
Total Services
6,377
Medicare Billing
$346,110
Procedure Codes
104
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 221 | 267 | $66,750 | $17,073 | 25.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 102 | 182 | $25,562 | $10,791 | 42.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 162 | 162 | $22,356 | $8,298 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 62 | 80 | $20,242 | $5,835 | 28.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 40 | 64 | $13,378 | $5,695 | 42.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 48 | 48 | $17,280 | $4,357 | 25.2% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Facility | 2023 | 47 | 47 | $11,549 | $3,769 | 32.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 16 | 24 | $11,888 | $3,644 | 30.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 31 | 34 | $11,560 | $3,409 | 29.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 59 | 59 | $10,110 | $3,316 | 32.8% |
| 75561 | Mri scan of heart before and after contrast | Facility | 2023 | 28 | 28 | $9,072 | $2,478 | 27.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $5,666 | $1,712 | 30.2% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 17 | 17 | $3,672 | $1,392 | 37.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $3,360 | $1,374 | 40.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 78 | 78 | $3,432 | $1,223 | 35.6% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 12 | 13 | $4,273 | $1,064 | 24.9% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 20 | 20 | $2,560 | $1,004 | 39.2% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 85 | 85 | $2,635 | $909.88 | 34.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 163 | 168 | $3,024 | $892.32 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 23 | 24 | $4,320 | $887.36 | 20.5% |
| 75572 | Ct scan of heart structure with contrast | Facility | 2023 | 16 | 16 | $2,624 | $883.04 | 33.7% |
| 0504T | Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review | Facility | 2023 | 13 | 13 | $2,574 | $425.75 | 16.5% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 24 | 24 | $1,224 | $317.32 | 25.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $533.00 | $140.66 | 26.4% |
| 75565 | Mri scan of blood flow of heart | Facility | 2023 | 11 | 11 | $302.00 | $100.65 | 33.3% |
About Dr. Ryan Daly, M.D
Dr. Ryan Daly, M.D is a Cardiovascular Disease healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2008. The National Provider Identifier (NPI) number assigned to this provider is 1598937484.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Daly, M.D has received a total of $28,865 in payments from pharmaceutical and medical device companies, with $748.06 received in 2024. These payments were reported across 220 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($22,100).
As a Medicare-enrolled provider, Daly has provided services to 5,508 Medicare beneficiaries, totaling 6,377 services with total Medicare billing of $346,110. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Indianapolis, IN
- Active Since 03/31/2008
- Last Updated 04/26/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1598937484
Products in Payments
- FARXIGA (Drug) $23,794
- WATCHMAN (Device) $983.08
- ENTRESTO (Drug) $665.69
- XARELTO (Drug) $380.84
- JARDIANCE (Drug) $312.29
- BRILINTA (Drug) $244.85
- NAEOTOM Alpha (Device) $227.70
- OPDIVO (Biological) $222.44
- Repatha (Biological) $159.90
- FFRct (Device) $154.65
- WATCHMAN Access System (Device) $140.65
- ELIQUIS (Drug) $127.11
- INVOKANA (Drug) $113.66
- VERQUVO (Drug) $106.90
- SAMSCA (Drug) $102.13
- VYNDAQEL (Drug) $59.28
- Ozempic (Drug) $52.94
- WATCHMAN FLX (Device) $46.99
- LEQVIO (Drug) $46.42
- Corlanor (Drug) $44.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Indianapolis
Eric Prystowsky, Md, MD
Cardiovascular Disease — Payments: $1.7M
Cardiovascular Disease $1.7M
Dr. Vijay Rao, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $431,147
Cardiovascular Disease $431,147
James Hermiller, Md, MD
Cardiovascular Disease — Payments: $380,511
Cardiovascular Disease $380,511
Dr. Atul Chugh, M.d, M.D
Cardiovascular Disease — Payments: $213,637
Cardiovascular Disease $213,637
Noel Dasgupta, Md, MD
Cardiovascular Disease — Payments: $164,975
Cardiovascular Disease $164,975
Michael Ball, Md, MD
Cardiovascular Disease — Payments: $131,315
Cardiovascular Disease $131,315